MedTrace Logo

FreeStyle Libre Flash Glucose Monitoring System Accuracy Study

NCT03141892 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2017-07-11

No results posted yet for this study

Summary

This is a pivotal, non-randomized, single arm, multi-center, prospective, non-significant risk study to evaluate the FreeStyle Libre Flash Glucose Monitoring System.

Conditions

Interventions

DEVICE

FreeStyle Libre Flash Glucose Monitoring System

Blood Glucose Monitoring

Sponsors & Collaborators

  • Abbott Diabetes Care

    lead INDUSTRY

Principal Investigators

  • Shridhara Karinka, PhD · Abbott Diabetes Care

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-13
Primary Completion
2017-05-23
Completion
2017-05-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03141892 on ClinicalTrials.gov